Stockscreener 앱 받기
18.78
0.27%
0.05
시간 외 거래:
18.75
-0.03
-0.16%
전일 마감가:
$18.73
열려 있는:
$18.8
하루 거래량:
299.39K
Relative Volume:
0.90
시가총액:
$522.97M
수익:
$242.12M
순이익/손실:
$-351.72M
주가수익비율:
-1.4131
EPS:
-13.29
순현금흐름:
$24.82M
1주 성능:
+115.37%
1개월 성능:
+117.11%
6개월 성능:
+31.05%
1년 성능:
-14.44%
1일 변동 폭
$18.77
$18.82
1주일 범위
$8.36
$18.98
52주 변동 폭
$8.15
$22.18
Zimvie Inc Stock (ZIMV) Company Profile
명칭
Zimvie Inc
전화
800-342-5454
주소
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
ZIMV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
18.78 | 522.97M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-04-10 | 개시 | B. Riley Securities | Buy |
| 2025-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-16 | 업그레이드 | Needham | Hold → Buy |
| 2023-11-16 | 개시 | Needham | Hold |
| 2022-12-21 | 개시 | Barclays | Underweight |
| 2022-06-17 | 개시 | JP Morgan | Neutral |
| 2022-03-18 | 개시 | Guggenheim | Neutral |
모두보기
Zimvie Inc 주식(ZIMV)의 최신 뉴스
What drives ZimVie Inc. stock priceFree Stock Chart Pattern Guide - Autocar Professional
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China - The Manila Times
ZimVie partners with Osstem Implant to expand in Chinese dental market By Investing.com - Investing.com South Africa
ZimVie partners with Osstem Implant to expand in Chinese dental market - Investing.com UK
ZimVie Targets Massive 10M Unit Chinese Dental Market Through Exclusive Osstem Partnership - Stock Titan
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
ZimVie Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
Is ZimVie Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc.ZIMV - The Globe and Mail
Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers - insights.citeline.com
ARCHIMED To Buy ZimVie In $730 Million Deal - Pulse 2.0
ZimVie upgraded to Equal Weight from Underweight at Barclays - TipRanks
ZimVie to sell to investment firm for about $730M - MedTech Dive
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger - Investing.com Australia
What analysts say about ZimVie Inc. stockHigh-yield portfolio picks - jammulinksnews.com
Dental Implants and Prosthetics Market is projected to reach US$ - openPR.com
ARCHIMED to acquire life sciences company ZimVie for $730m - Yahoo Finance
ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan - MSN
Latham & Watkins Advises ARCHIMED in US$730 Million Acquisition of ZimVie Inc. - Latham & Watkins LLP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.
ZimVie Sells For $730 Million In Archimed Buyout - Finimize
ArchiMed To Acquire ZimVie in $730M Deal - USA Herald
Latham And Cravath Steer $730M ZimVie Take-Private Deal - Law360
ZimVie Acquired by Archimed Affiliate for $730 Million, Going Private - Medical Device and Diagnostic industry
Small Medtech Catapults 122% On Its Second Takeover Deal - Investor's Business Daily
ZimVie to be acquired by Archimed in $730M deal - MassDevice
ZimVie stock soars after $730 million acquisition deal with ARCHIMED By Investing.com - Investing.com Canada
ZimVie stock soars after $730 million acquisition deal with ARCHIMED - Investing.com India
The ZimVie Takeover: A Strategic Bet on Dental Innovation and MedTech Consolidation - AInvest
Hold Rating Maintained on ZimVie Inc Amid Acquisition by ARCHIMED - TipRanks
ZimVie's $730M Take-Private by Archimed: A Strategic Exit and Value Realization Opportunity - AInvest
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
Dental devicemaker ZimVie to be bought by ArchiMed in $730M deal - Fierce Biotech
ZimVie shares surge after go-private deal with Archimed - TradingView
ZimVie to be acquired by ARCHIMED in $730 million deal - Investing.com
ZIMV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ZimVie Inc. Is Fair to Shareholders - Business Wire
ZimVie Stock (ZIMV) Rockets 120% on ARCHIMED Deal - TipRanks
ZimVie Stock Soars 121.92% on ARCHIMED Acquisition Deal - AInvest
ZimVie to be acquired by ARCHIMED for $19.00 per share in cash - TipRanks
ZimVie Inc to be Acquired by ARCHIMED - TipRanks
ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash - The Manila Times
Dental Tech Leader ZimVie Gets Massive 99% Premium in $730M ARCHIMED Buyout Deal - Stock Titan
Zimvie Inc (ZIMV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
자본화:
|
볼륨(24시간):